Last updated: April 1, 2026

Cerebral palsy is a disorder of movement and posture due to a non-progressive brain injury or malformation, which results in permanent neurological damage. The most common cause is anoxic brain injury during the perinatal period or before 2 years of age.

It affects 2 in 1000 live births and is the most common cause of major motor impairment.

Causes of cerebral palsy

CauseExamples
AntenatalMaternal infection, trauma during pregnancy
PerinatalBirth asphyxia, pre-term birth
Post-natalMeningitis, intraventricular hemorrhage, severe neonatal jaundice, and head injury

Classification of cerebral palsy

ClassificationDescription
Spastic CP (Pyramidal, 75%)Increased muscle tone with increased muscle velocity (hypertonia) and hyperreflexia. Most common subtype. Due to damage to the upper motor neurons.
Athetoid (Dyskinetic/Extrapyramidal)Problems controlling muscle tone with hypertonia and hypotonia, which cause involuntary writhing movements and oro-motor problems. Results from damage to the basal ganglia.
AtaxicIssues with coordination and balance. Results from damage to the cerebellum
HypotonicLoss of muscle tone and strength, resulting in weakness and floppiness
MixedA mix of spastic, dyskinetic, and ataxic features due to damage to different portions of the brain

Classification according to limbs affected

ClassificationDescription
QuadriplegicAll 4 extremities are affected severely. Also often involves muscles of facial expression, seizures, speech disturbances, and other impairments.
DiplegicTwo contralateral extremities (typically both lower extremities) are affected
HemiplegicTwo ipsilateral extremities are affected
MonoplegicOne limb is affected
  • POSTER criteria for diagnosis
    • Posturing
    • Oropharyngeal problems: tongue thrusts, grimacing, and swallowing difficulties
    • Strabismus
    • Tone – increased or decreased
    • Evolutionary responses: persistent primitive reflexes or failure to develop equilibrium and protective responses
    • Reflexes: deep tendon reflexes are increased, and plantar reflexes are upgoing
  • Signs and symptoms
    • Failure to meet milestones
    • Increased or decreased tone (generally or in affected limbs)
    • Hand preference before 18 months
    • Problems with coordination, speech, or walking
    • Feeding or swallowing problems
    • Learning difficulties
  • Physical examination
    • Hemiplegic/diplegic gait (UMN lesion): legs extended with plantarflexion of the feet and toes. The leg is swung around in a large semicircle when it is moved from behind to the front.
    • Good muscle bulk
    • Hypertonia
    • Spasticity (muscle stiffness or tightness that increases with muscle contraction velocity)
    • Brisk reflexes
    • Slightly reduced power
    • Athetoid movements
    • Test for coordination
  • Investigations
    • Cranial ultrasound: intraventricular hemorrhage in neonates
    • MRI: periventricular leukomalacia, hemorrhage
    • EEG: for seizures
    • TORCH screen: to rule out congenital infections
  • Supportive treatment
    • Physiotherapy: to stretch and strengthen muscles, maximize function, and prevent contractures
    • Occupational therapy: to help the patients manage everyday activities
    • Speech and language therapy: to help with speech and swallowing
    • Dieticians: to ensure they meet nutritional requirements. Some children can be fed using a PEG or NG tube
    • Mobility assistance, e.g., walkers
    • Bracing
    • Social worker: to help with benefits and support
    • Charities and support groups provide opportunities
  • Pharmacological treatment
    • Muscle relaxants, e.g., baclofen, dantrolene, or botulinum, for spasticity and contractures
      • Baclofen is preferred intrathecal
    • Anti-epileptic drugs for seizures
    • Anticholinergic, e.g., glycopyrrolate or benzhexol, for excessive drooling
    • Proton pump inhibitors for acid reflux
    • Laxatives and suppositories for constipation
  • Indications and options for operative treatment
    • Hip subluxation or dislocation: tendon release and osteotomies
    • Knee contractures: hamstring lengthening procedures
    • Foot and ankle deformities: tendon transfers or osteotomies
    • Selective dorsal rhizotomy to relax spastic muscles
  • Complications and associated conditions
    • Learning disability
    • Epilepsy
    • Kyphoscoliosis
    • Muscle contractures
    • Hearing and visual impairment
    • Gastro-esophageal reflux

Examining for Spasticity

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *